Mandate

Vinge advises First State Investments on acquisition of E.ON Gas Sverige AB.

April 27, 2018 M&A

Vinge has advised European Diversified Infrastructure Fund II ("EDIF II"), an infrastructure fund managed by First State Investments, in connection with the acquisition of E.ON Gas Sverige AB.

E.ON Gas Sverige AB is the part of E.ON Sverige AB which owns gas networks. First State Investments is a global fund manager with more than 20 years of infrastructure investment experience. EDIF II, where investors are predominantly European pension funds, focuses on long-term investments in European infrastructure companies.

The Vinge team advising First State Investments includes Christoffer Thalin together with Kristoffer Franzkeit, Niklas Törnell, Anna Jonson, Anna Thuresson, Henrik Borna, Freja Ljungdell Kristensen, Daniel Melander Björner, Mathias Lindquist, Jack Bengtsson and Emelie Svensäter Jerntorp. Henrik Ossborn and Fredrik Christiansson advised on the financing of the transaction. Björn Mullaart and Rickard Vernet provided competition law advice.


 

Related

Vinge advises Atria Sverige in conjunction with an investment in Cookin Food

Atria Sverige has acquired a 25 per cent stake in the Swedish convenience food company Cookin Food Sweden AB. The transaction has been performed through the acquisition of shares in Bite Delight AB, which owns Cookin Food Sweden AB. Atria holds an option to acquire the remaining shares in Bite Delight AB after 2028.
March 04, 2026

Vinge advises Revivo Group on the acquisition of Solidenergy

Revivo Group, a portfolio company of Helix Kapital, has acquired Solidenergy, a leading provider of surface treatment services in the Norwegian market. The company operates within the energy, offshore and infrastructure sectors and is headquartered in Ågotnes outside Bergen. Solidenergy employs approximately 600 people.
March 03, 2026

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a partially guaranteed rights issue which is expected to provide Oncopeptides with proceeds of approximately SEK 200 million before deduction of transaction costs.
March 03, 2026